NCT00382304View on ClinicalTrials.gov

A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

September 30, 2007

Conditions
Pseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea
Interventions
DRUG

tolevamer potassium-sodium (GT267-004)

Trial Locations (8)

T6G 2B7

Edmonton

V9S 2B7

Nanaimo

V3Z 1M9

Vancouver

K1H 8L6

Ottowa

L4C 4Z3

Richmond Hill

H3T 1E2

Montreal

G5L 5T1

Rimouski

J1H 5N4

Sherbrooke

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00382304 - A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea | Biotech Hunter | Biotech Hunter